Gender Differences in the Ratio of Eicosapentaenoic Acid to Arachidonic Acid in an Inland Prefecture, Tochigi: Tochigi Ryomo EPA/AA Trial in Coronary Artery Disease (TREAT-CAD)-Reference-Cited by-同舟云学术

Gender Differences in the Ratio of Eicosapentaenoic Acid to Arachidonic Acid in an Inland Prefecture, Tochigi: Tochigi Ryomo EPA/AA Trial in Coronary Artery Disease (TREAT-CAD)

Published:2014 Issue:3 Volume:53 Page:177-182
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kitagawa Yoshiyuki¹,Abe Shichiro¹,Toyoda Shigeru¹,Watanabe Shintaro²,Ebisawa Katsuto³,Murakami Yoshiaki⁴,Takahashi Toshiyuki⁵,Sugimura Hiroyuki⁶,Taguchi Isao¹,Inoue Teruo¹

Affiliation:

1. Department of Cardiovascular Medicine, Dokkyo Medical University, Japan

2. Department of Cardiology, Sano Kosei Hospital, Japan

3. Department of Cardiology, Shimotsuga General Hospital, Japan

4. Department of Cardiology, Haga Red Cross Hospital, Japan

5. Department of Cardiology, Ashikaga Red Cross Hospital, Japan

6. Department of Cardiology, Nikko Medical Center, Dokkyo Medical University, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/53/3/53_53.0618/_pdf

Reference25 articles.

1. 1. Inoue T, Node K. Vascular failure -a new clinical entity for vascular disease-. J Hypertens 24: 2121-2130, 2006.

2. 2. LaRosa JC, Grundy SM, Waters DD, et al. Treating to New Targets (TNT) Investigators. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 352: 1425-1435, 2005.

3. 3. Baigent C, Keech A, Kerney PM, et al. Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 patients in 14 randomized trials of statins. Lancet 366: 1267-1278, 2005.

4. 4. Alagona P Jr. Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy. Am J Manag Care 15 (suppl): 65-67, 2009.

5. 5. Dyerberg J, Bang HO, Hjorne N. Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 28: 958-966, 1975.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics of Icosapent Ethyl: An Open‐Label, Multiple Oral Dose, Parallel Design Study in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2022-07-03

2. Sex Differences in Response to Fatty Acids in Cardiovascular Health and Disease;Sex Differences in Heart Disease;2020

3. Impact of Preprocedural Serum Eicosapentaenoic Acid to Arachidonic Acid Ratio on Post-Ablation Recurrence of Atrial Fibrillation;International Heart Journal;2019-11-30

4. Eicosapantaenoic acid treatment based on the EPA/AA ratio in patients with coronary artery disease: follow-up data from the Tochigi Ryomo EPA/AA Trial in Coronary Artery Disease (TREAT-CAD) study;Hypertension Research;2018-09-20

5. Serum adiponectin and TNFα concentrations are closely associated with epicardial adipose tissue fatty acid profiles in patients undergoing cardiovascular surgery;IJC Heart & Vasculature;2018-03